Cranford James A, Bohnert Kipling M, Perron Brian E, Bourque Carrie, Ilgen Mark
Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, United States.
Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, United States; VA Center for Clinical Management Research (CCMR), Veterans Health Administration, 2215 Fuller Road, Mail Stop 152, Ann Arbor, MI 48105, United States.
Drug Alcohol Depend. 2016 Dec 1;169:41-47. doi: 10.1016/j.drugalcdep.2016.10.008. Epub 2016 Oct 15.
To examine the prevalence and correlates of vaporization (i.e., "vaping") as a route of cannabis administration in a sample of medical cannabis patients.
Adults ages 21 and older (N=1485M age=45.1) who were seeking medical cannabis certification (either for the first time or as a renewal) at medical cannabis clinics in southern Michigan completed a screening assessment. Participants completed measures of route of cannabis administration, cannabis use, alcohol and other substance use.
An estimated 39% (n=511) of the sample reported past-month cannabis vaping, but vaping as the sole route of cannabis administration was rare. Specifically, only 30 participants (2.3% of the full sample and 5.9% of those who reported any vaping) indicated vaping as the sole route of cannabis administration. The majority (87.3%) of those who reported vaping also reported smoking (combustion) as a route of cannabis administration. Being younger than age 44, having more than a high school education, engaging in nonmedical stimulant use, being a returning medical cannabis patient, and greater frequency of cannabis use were associated with higher odds of vaping at the bivariate level and with all variables considered simultaneously.
Vaping appears to be relatively common among medical cannabis patients, but is seldom used as the sole route of cannabis administration.
highlight the importance of monitoring trends in vaping and other substance use behaviors in this population and underscore the need for longitudinal research into the motives, correlates, and consequences of cannabis vaping in medical cannabis patients.
在医用大麻患者样本中，研究大麻雾化吸入（即“吸电子烟”）作为一种大麻给药途径的流行情况及其相关因素。
年龄在21岁及以上（N = 1485；平均年龄 = 45.1岁）、在密歇根州南部医用大麻诊所寻求医用大麻认证（首次认证或续证）的成年人完成了一项筛查评估。参与者完成了关于大麻给药途径、大麻使用、酒精及其他物质使用的测量。
估计39%（n = 511）的样本报告在过去一个月有过大麻雾化吸入，但仅将雾化吸入作为大麻给药途径的情况很少见。具体而言，只有30名参与者（占整个样本的2.3%，占报告有任何雾化吸入情况者的5.9%）表示仅将雾化吸入作为大麻给药途径。报告有雾化吸入情况的人中，大多数（87.3%）也报告将吸烟（燃烧）作为大麻给药途径。在双变量水平以及同时考虑所有变量的情况下，年龄小于44岁、拥有高中以上学历、使用非医用兴奋剂、是复诊医用大麻患者以及大麻使用频率较高与雾化吸入的较高几率相关。
雾化吸入在医用大麻患者中似乎相对普遍，但很少被用作唯一的大麻给药途径。
突出了监测该人群中雾化吸入及其他物质使用行为趋势的重要性，并强调了对医用大麻患者中大麻雾化吸入的动机、相关因素及后果进行纵向研究的必要性。
